BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $442,000 | +14.5% | 5,000 | 0.0% | 0.01% | +8.3% |
Q3 2021 | $386,000 | -53.7% | 5,000 | -50.0% | 0.01% | -64.7% |
Q2 2021 | $834,000 | -71.3% | 10,000 | -74.0% | 0.03% | -73.8% |
Q1 2021 | $2,907,000 | +63.3% | 38,500 | +64.5% | 0.13% | -11.6% |
Q3 2020 | $1,780,000 | +0.2% | 23,400 | +62.5% | 0.15% | +21.5% |
Q2 2020 | $1,776,000 | – | 14,400 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Maven Securities LTD | 38,500 | $2,907,000 | 0.13% |
BOOTHBAY FUND MANAGEMENT, LLC | 75 | $566,000 | 0.02% |
GROUP ONE TRADING, L.P. | 150,100 | $11,334,000 | 0.02% |
SIMPLEX TRADING, LLC | 752 | $5,678,000 | 0.01% |
IMC-Chicago, LLC | 57,700 | $4,357,000 | 0.01% |
Worth Venture Partners, LLC | 4,500 | $13,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 43,400 | $3,277,000 | 0.00% |